Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
8,122,625
-
Total 13F shares
-
3,769,440
-
Share change
-
+126,585
-
Total reported value
-
$134,565,447
-
Price per share
-
$35.71
-
Number of holders
-
42
-
Value change
-
+$4,551,552
-
Number of buys
-
16
-
Number of sells
-
15
Institutional Holders of LUMOS PHARMA INC - Common Stock (LUMO) as of Q4 2020
As of 31 Dec 2020,
LUMOS PHARMA INC - Common Stock (LUMO) was held by
42 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,769,440 shares.
The largest 10 holders included
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), NEA Management Company, LLC, Blackstone Group Inc., Lion Point Capital, LP, RENAISSANCE TECHNOLOGIES LLC, Opaleye Management Inc., VANGUARD GROUP INC, Jefferies Group LLC, WELLS FARGO & COMPANY/MN, and BlackRock Inc..
This page lists
42
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.